Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, an... Cara Therapeutics Inc is an emerging biotechnology company involved in the development of novel therapeutics to treat human diseases associated with inflammation, pain, and pruritus. Cara's most advanced compound, CR845, aims to treat acute pain and pruritus. This patented compound has analgesic, anti-inflammatory, and antipruritic properties that can be used for multiple therapeutic applications. Additionally, Cara's objective is to use its proprietary drug-screening technology to develop a future pipeline of first-in-class molecules with analgesic and anti-inflammatory features. 더 보기
STAMFORD, Conn., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq: CARA) (the “Company”), today announced that a 1-for-12 reverse stock split of its outstanding shares of common...
기간 | 변동 | 변동 % | 시가 | 고가 | 저가 | 평균 일일 거래량 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 1.0699 | 23.4622047762 | 4.5601 | 6 | 4.56 | 66042 | 5.39216625 | CS |
4 | 1.19 | 26.8018018018 | 4.44 | 6.36 | 3.96 | 226775 | 4.63899647 | CS |
12 | 2.15 | 61.7816091954 | 3.48 | 6.36 | 2.7084 | 1592103 | 4.15399656 | CS |
26 | 1.07 | 23.4649122807 | 4.56 | 6.36 | 2.7084 | 912258 | 4.03876045 | CS |
52 | -1.45 | -20.4802259887 | 7.08 | 13.8 | 2.7084 | 833469 | 5.29236362 | CS |
156 | -131.89 | -95.9060500291 | 137.52 | 167.58 | 2.7084 | 725839 | 44.64209276 | CS |
260 | -181.57 | -96.9925213675 | 187.2 | 355.7676 | 2.7084 | 726370 | 105.21066713 | CS |
도움 및 지원받기: kr-support@advfn.com
ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관